Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oxnard, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oxnard, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Maria, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
South Lake Tahoe, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
South Lake Tahoe, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Victorville, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Victorville, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lakewood, CO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Trumbull, CT
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hollywood, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kissimmee, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sebring, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sebring, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Gainesville, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Woodstock, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Woodstock, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Alton, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alton, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rockford, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockford, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bettendorf, IA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
East Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Woodbury, MN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Woodbury, MN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Butler, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Butler, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Dover, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Dover, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Brooklyn, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Plainview, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plainview, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Asheboro, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Asheboro, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tabor City, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tabor City, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Akron, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Centerville, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Centerville, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Middletown, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Middletown, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bend, OR
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Duncansville, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lansdale, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lansdale, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Myrtle Beach, SC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jackson, TN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Southlake, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Midlothian, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Midlothian, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winchester, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winchester, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials